TITLE

Praxair and Merck Dissolve Alliance

PUB. DATE
May 2001
SOURCE
Gases & Welding Distributor;May/Jun2001, Vol. 45 Issue 3, p10
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the discontinuation of the strategic alliance between Danbury, Connecticut-based industrial machinery manufacturer Praxair Inc. and electronic chemical supplier Merck KGaA, signed by them in 1999. Terms of the discontinued alliance; Possibility of the two companies working together inspite of the dissolution of the alliance.
ACCESSION #
7629502

 

Related Articles

  • Praxair, Merck Detail Electronics Partnership. Moore, Samuel K. // Chemical Week;4/14/1999, Vol. 161 Issue 14, p13 

    Provides information on the strategic alliance formed by Praxair company and Merck KGaA. Terms under the electronic chemicals partnership; Benefits of the deal for both companies.

  • Merck and Praxair Dissolve Electronic Chemicals Alliance. Hume, Claudia // Chemical Week;5/2/2001, Vol. 163 Issue 18, p18 

    Reports on the decision of Merck KGAA and Praxair to dissolve their distribution and research alliance for electronic chemicals. Discussion on the sale of electronic gases by the end of 1999; Plan of Merck to form a joint venture with a chemical company in the United States.

  • Take stock in.  // Pharmaceutical Executive;May98, Vol. 18 Issue 5, p132 

    Focuses on an alliance formed by Merck KGaA with Pharmaceutical Resources (PhR). Terms of the agreement.

  • Pharmaceutical Resources, forms critical alliance with...  // Hudson Valley Business Journal;04/27/98, Vol. 8 Issue 26, International trade in the Hudson Val 

    Reports that Pharmaceutical Resources Incorporated has formed a strategic alliance with Merck KGaA company. Cash purchase price per share; Significance of the strategic alliance to Pharmaceutical.

  • Intrexon gets CAR-T deal. Investor's Business Daily // Investors Business Daily;3/31/2015, pA02 

    The article reports on the agreement signed by Darmstadt, Germany-based healthcare and life sciences company Merck KGaA with biotechnology firm Intrexon Corp. for the development and commercialization of chimeric antigen receptor T-cell (CAR-T) immunotherapy.

  • Merck/Praxair Off; Merck/Sachtleben On. Milmo, Sean // Chemical Market Reporter;04/30/2001, Vol. 259 Issue 18, p8 

    Reports on the termination of a marketing and development alliance between Merck KGaA and Praxair. Reason for the breakup of the alliance; Brief information on both chemical companies.

  • Altana: putting the feelers out for a suitable partner.  // PharmaWatch: Monthly Review;Jun2006, Vol. 5 Issue 6, p29 

    The article reports on Germany-based drug company Altana's confirmation of its plan to seek a suitable strategic partner for its pharmaceutical business. The names of any possible buyers are yet to be disclosed. However, it is possible that Merck KG&A could be up for the deal. Altana has...

  • Peregrine Builds Up Technology and Drug Pipeline. Mirasol, Feliza // Chemical Market Reporter;1/31/2005, Vol. 267 Issue 5, p7 

    This article reports that Peregrine Pharmaceuticals Inc. last week signed a deal allowing it to tap into Merck KGaA's protein expression expertise for the purpose of developing product candidates. Under the collaboration, Peregrine will use Merck's protein expression technologies, developed by...

  • Merck Plans Europe-Wide E-Commerce Service.  // Chemical Market Reporter;12/20/99, Vol. 256 Issue 25, p7 

    Reports on the plans of Merck KGaA to establish a Europe-wide electronic-commerce service in laboratory chemicals through its alliance with Chemdex Corp., an electronic-commerce life science company. Significance of the plan; Partnership deal between Merck and Bracco Group.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics